A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01643304
First received: July 16, 2012
Last updated: November 20, 2013
Last verified: November 2013

July 16, 2012
November 20, 2013
May 2012
Not Provided
Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01643304 on ClinicalTrials.gov Archive Site
  • Social consequences of heavy menstrual bleedings assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
  • Costs; e.g. pads, absence from work, loss of income assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
  • The treatments given for heavy menstrual bleedings, as surgery or medication assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings
A Swedish Cross-sectional Study With Questionnaire to Investigate Perception of Menstrual Bleeding

This field based, questionnaire study will document observational data on womens perception of menstrual bleeding in a cross-section of women in Sweden. Each subject will complete the questionnaire at one occasion.

Not Provided
Observational
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Subjects included in the SIFO (Swedish institute of market research) volontary subject pool.

Menorrhagia
Behavioral: No drug
No drug intervention. The intervention is a questionnaire with quality of life and perception of menstrual bleedings. All subjects will complete both questionnaires.
Group 1
Intervention: Behavioral: No drug
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1547
June 2012
Not Provided

Inclusion Criteria:

  • All women 40-45 years available in the web-panel of SIFO
  • Completion of the web-based questionnaire

Exclusion Criteria:

  • None
Female
40 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01643304
16384, NN1223SE
No
Bayer
Bayer
Not Provided
Study Director: Bayer Study Director Bayer
Bayer
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP